12th Annual Texas Conference on Health Disparities

Evidence-Based Approaches to Reducing Cancer Health Disparities: Discover, Develop, Deliver & Disseminate

June 8 and 9, 2017

The 12th Annual Conference on Health Disparities, Evidence-Based Approaches to Reducing Cancer Health Disparities focuses on Breast, Colorectal and Prostate Cancers. Invited experts from across the United States, community partners, faculty and students will convene to learn about the latest basic, clinical, community and translational approaches to discover, develop, deliver and disseminate information to eliminating cancer health disparities. 

Keynote Address

• From Awareness to Action: Addressing Cancer Disparities, Rebecca Garcia, PhD, Chief Prevention and Communication Officer, Cancer Prevention and Research Institute of Texas (CPRIT)

Breast Cancer Session:

• Metabolic Basis of Racial Disparity in Breast Cancer, Arun Sreekumar, PhD, Professor and Director Metabolomics, Department of Molecular and Cell Biology, Baylor College of Medicine, Houston, Texas
• Racial/ethnic disparities in obesity and breast cancer, Elisa Bandera, MD, PhD, Professor and Co-Leader, Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey
• Clinical perspective 0n Breast Cancer, Robyn Young, MD, Clinical Director, Breast Cancer, Center for Cancer and Blood Disorders, Fort Worth

Prostate Cancer Session:

• Prostate Cancer Genome: Race Associated Differences, Shiv Srivastava, PhD, Professor and Co-Director, Center for Prostate Disease Research (CPDR), Department of Surgery, Uniformed Services University of the Health Sciences
• Prostate Cancer Diagnosis and Treatment 2017: Special Focus on Race and Ethnicity, Judd W Moul, MD, FACS, James H Semans MD Professor of Surgery, Director, Duke Prostate Center, Duke Cancer Institute, Division of Urology, Department of Surgery, Duke University Medical Center, Durham, NC
• Healthy Lives Matter: Prostate Cancer Risk & Preventative Efforts, Commissioner Roy C. Brooks, Tarrant County, Texas

Colorectal Cancer Session:

• Noncoding RNA Biomarkers in Gastrointestinal Cancers, Ajay Goel, PhD, Director, Center for Gastrointestinal Research, Director, Center for Translational Genomics and Oncology, Michael E Ramsay Chair in Translational Epigenomics and Oncology, Baylor Scott & White Research Institute, Sammons Cancer Center, Dallas, TX
• MultiModal Colorectal cancer screening intervention aimed to address health disparities, Milena Gould Suarez, MD, FACG, Associate Professor of Medicine, Associate Program Director, GI Fellowship, Baylor College of Medicine
• Income and age disparities in access to cancer clinical trials: Models, evidence, and implications, Joseph Unger, PhD, Assistant Member, Fred Hutchinson Cancer Research Center, Affiliate Assistant Professor, University of Washington, Seattle, WA